Ieq Capital, LLC Seagen Inc. Transaction History

Ieq Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$191.51 - $216.16 $61,091 - $68,955	319 Added 16.11%	2,299 $487,000
Q2 2023 Aug 07, 2023	BUY	$187.64 - $206.25 $35,463 - $38,981	189 Added 10.55%	1,980 $381,000
Q1 2023 May 01, 2023	BUY	$127.59 - $203.08 $228,513 - $363,716	1,791 New	1,791 $362,000
Q3 2022 Nov 03, 2022	BUY	$135.27 - $180.11 $130,670 - $173,986	966 Added 81.93%	2,145 $294,000
Q2 2022 Jul 27, 2022	SELL	$108.81 - $179.33 $34,383 - $56,668	-316 Reduced 21.14%	1,179 $209,000
Q1 2022 Apr 26, 2022	BUY	$119.61 - $157.85 $178,816 - $235,985	1,495 New	1,495 $215,000
Q4 2021 Jan 31, 2022	SELL	$142.57 - $190.86 $192,469 - $257,661	-1,350 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$142.45 - $169.82 $192,307 - $229,257	1,350 New	1,350 $229,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ieq Capital, LLC with notifications on news.